Erin Brown Jones

Washington, D.C.
  • 555 Eleventh Street, NW
  • Suite 1000
  • Washington, D.C. 20004-1304
  • USA

Erin Brown Jones advises clients on enforcement, compliance, and litigation matters across a range of regulatory regimes, with a focus on the US Foreign Corrupt Practices Act (FCPA) and US securities laws and regulations.

Ms. Brown Jones was recognized in Global Investigations Review’s 2020 “40 Under 40” list recognizing the next generation of outstanding investigations specialists.

Ms. Brown Jones represents clients in both domestic and cross-border investigations, and has experience collaborating with forensic auditors, navigating government-imposed compliance monitor decrees, and advocating in front of government agencies. Ms. Brown Jones has investigative experience with the Department of Justice (DOJ), Securities and Exchange Commission (SEC), Consumer Financial Protection Bureau (CFPB), Drug Enforcement Administration (DEA), Federal Bureau of Investigation (FBI), State Department, and Department of Commerce, as well as working with clients facing Congressional investigations. Her experience includes investigations around the world, including field work for major multinational companies in at least 14 countries across Asia, Europe, the Middle East, and the Americas.

In addition to her investigations work, Ms. Brown Jones also works closely with clients across industries – including the manufacturing, technology, pharmaceutical, aerospace, healthcare, and oil and gas industries – to review and enhance their internal compliance programs, including drafting policies and procedures, conducting risk assessments, and advising companies with respect to innovative compliance monitoring and analytics. Ms. Brown Jones also regularly advises clients in connection with cross-border M&A and capital markets transactions, including pre- and post-acquisition due diligence and counselling.

Prior to her experience at Latham, Ms. Brown Jones held fellowships with the Department of Justice’s National Security Division and the Department of Defense’s (DOD) Office of Force Transformation, and also served in the AmeriCorps program.

Ms. Brown Jones previously was a member of Latham’s Recruiting Committee, and currently serves on the firm’s Equal Employment Opportunity (EEO) Review Board.

Ms. Brown Jones’ recent investigations experience includes:

  • A major technology company to obtain a declination from DOJ and a reasonable SEC resolution in an investigation of high-profile alleged FCPA violations in India implicating members of senior management
  • A global manufacturing company in conducting a virtual/remote investigation of potential pre-acquisition bribery by a recently acquired subsidiary in India
  • Mylan N.V. in response to investigations by the House Oversight and Government Reform Committee and the Senate Judiciary Committee, among others, regarding the EpiPen Auto-Injector
  • Several multinational life sciences companies in support of internal and government-facing anti-corruption investigations around the world, including field work in Indonesia, Saudi Arabia, Romania, India, China, and Macedonia
  • Major healthcare company in a DOJ and SEC insider trading case, which was resolved without action against the company or company employees
  • A global insurance firm in responding to anti-bribery and anti-money laundering investigations facing both the DOJ and UK Serious Fraud Office
  • A lobbying and PR firm involved in a criminal investigation involving the Foreign Agents Registration Act
  • A US-based financial institution in connection with a CFPB investigation related to consumer banking, which resulted in the matter being closed
  • Multiple companies – including a major retailer and US healthcare facilities – in responding to investigations by the DEA, all of which resulted in reasonable resolutions
  • An international non-profit organization in conducting an internal investigation into employee misappropriation in the Democratic Republic of Congo, ultimately collaborating with US prosecutors regarding the matter
  • An energy company in an SEC investigation related to complex accounting and disclosure matters, resulting in no enforcement action
  • A US-based manufacturer in obtaining declinations from DOJ and the SEC related to alleged FCPA violations in Poland
  • Multiple aerospace and defense companies in conducting internal investigations and submitting voluntary disclosures to the Department of State’s Directorate of Defense Trade Controls, all of which were closed without action

Ms. Brown Jones’ transactional and compliance work includes:

  • A multinational manufacturing company in designing and conducting a comprehensive global anti-corruption risk assessment, including leading field work in Eastern Europe, the Middle East, Latin America, and Asia-Pacific
  • A global technology company in building a world-class anti-corruption compliance program in the wake of a major government investigation
  • A global food services company in designing and implementing a risk-based anti-corruption compliance program following an IPO
  • A multinational pharmaceutical company in conducting a global post-acquisition anti-corruption risk assessment, including leading field work and forensic accounting analysis in Eastern Europe
  • Several major companies – including a technology firm, logistics company, and oilfield services company – in providing real-time analysis and advice regarding third party compliance
  • A Middle Eastern transportation company in developing practical compliance guidance regarding industry-specific corruption risks
  • Multiple private equity firms in advising on anti-corruption risks with respect to acquisition and investment decisions
  • A multinational agriculture company in conducting anti-corruption due diligence on several high-risk acquisition targets in Brazil
  • Several non-profit organizations in designing, implementing, and executing risk-based anti-corruption compliance programs
  • Designing and conducting virtual compliance risk assessments, including for companies in the biotechnology, oil and gas, and aerospace industries
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.